Unveiling AI-Driven Accelerators to Enhance Clinical Trial Efficiency and Precision PRINCETON, N.J., Oct. 23, 2024 /PRNewswire/ -- EDETEK Inc., a…
NEW YORK, Oct. 23, 2024 /PRNewswire/ -- Target ALS, a leading organization dedicated to breaking down barriers to accelerate amyotrophic lateral…
– Karl Deonanan appointed Chief Financial Officer –– Matt DeZee named to newly established role, Chief Transformation and Strategy Officer – …
The conference, held in New Jersey, addresses critical aspects of clinical trials in the biopharmaceutical industry in the United States.Rui…
Investigator initiated trial seeks to validate safety, efficacy of the NanoKnife System in treating targeted tumors while reducing or delaying…
– Preclinical data demonstrate that inhibiting the p300 KAT domain reactivates p53 in HPV-driven tumors resulting in anti-tumor activity –SAN…
SHELTON, CT / ACCESSWIRE / October 22, 2024 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a clinical stage…
Healthcare executive to lead company’s business operations and growth strategyDURHAM, N.C., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Parexel, one of…
FREMONT, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative…
DENVER, Oct. 22, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary…